ULTRAGENYX PHARMACEUTICAL INC. Reports Q2 2026 Financial Results

2026-08-05SEC Filing 10-Q (0001193125-26-333233)

Please check the link below for details.

Ticker mentioned:RARE

Source:Original SEC Document ↗